The goal of drug discovery is to uncover new molecules with specific chemical properties that can be used to cure diseases. With the accessibility of machine learning techniques, the approach used in this search has become a significant component in computer science in recent years. To meet the Precision Medicine Initiative’s goals and the additional…
Kinases and Phosphatases Template
Write in a clean editor, then format for Kinases and Phosphatases in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Kinases and Phosphatases format
Kinases and Phosphatases is a peer-reviewed journal published by MDPI, covering Protein Kinase Regulation and GTPase Signaling, Protein Tyrosine Phosphatases, PI3K/AKT/mTOR signaling in cancer. Over its lifetime it has published 87 papers, which have received 318 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Kinases and Phosphatases 2023, 12, 45–58.
Formats any DOI in Kinases and Phosphatases style. No sign-up. |
| Abbreviation (ISO-4) | Kinases Phosphatases |
| Publishes research in | Protein Kinase Regulation and GTPase Signaling Protein Tyrosine Phosphatases PI3K/AKT/mTOR signaling in cancer Computational Drug Discovery Methods Microtubule and mitosis dynamics |
| ISSN | 2813-3757 |
| Citation impact (2-yr) | 1.63 |
| h-index | 9 |
| i10-index | 6 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Centre National de la Recherche Scientifique |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Kinases and Phosphatases per year
Citation impact of Kinases and Phosphatases by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Kinases and Phosphatases
Adenosine Monophosphate-Activated Protein Kinase (AMPK) is the major conserved regulator of cellular metabolism in eukaryotic cells, from yeast to mammals. Given its pivotal role, it is not surprising that alterations in its function may contribute to the pathogenesis of numerous human diseases. Indeed, AMPK has become a promising therapeutic target for several pathologies. In this…
Protein kinase CK2 is a Ser/Thr protein kinase that phosphorylates hundreds of substrates mainly related to survival and proliferation pathways. It has long been considered an anti-cancer drug target. However, during the recent COVID-19 pandemic, CK2 inhibitors have been repurposed as anti-SARS-CoV-2 drugs. This was based on the initial finding of CK2 among the proteins…
LYN proto-oncogene, Src family tyrosine kinase (Lyn) is a tyrosine kinase that belongs to the Src family (SFK). It is expressed as two isoforms in humans, LynA and LynB. Like other SFKs, Lyn consists of five protein domains, an N-terminal SH4 domain followed by a unique domain, the SH3 and SH2 domains, and a catalytic…
Protein kinase casein kinase 2 (CK2/CSNK2) is a pleiotropic kinase involved in many cellular processes and, accordingly, has been identified as a potential target for therapeutic intervention for multiple indications. Significant research effort has been invested into identifying CK2 inhibitors as potential drug candidates and potent and selective CK2 chemical probes to interrogate CK2 function.…